PANAROMIC
LIVE

Serial Number

79417416

Owner

DXCOVER LIMITED

Attorney

Alex P. Garens

Filing Date

May 28, 2024

Add to watchlist:

No watchlists yet
View on USPTO

PANAROMIC Trademark

Serial Number: 79417416 • Registration: 8172790

PANAROMIC is a trademark filed by DXCOVER LIMITED on May 28, 2024. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

DXCOVER LIMITED (4 trademarks)

Suite RC534, Royal College Building,

Entity Type: 99

Trademark Details

Filing Date

May 28, 2024

Registration Date

March 17, 2026

Published for Opposition

January 27, 2026

Goods & Services

Scientific apparatus and instruments for analysing biofluids and detecting diseases; laboratory apparatus and instruments for microscopy, namely, microscopes; scientific apparatus, namely, spectrometers and parts and fittings therefor; spectroscopes; scientific apparatus, namely, spectrophotometers for measuring the infrared spectrum of biofluids for the purpose of detecting diseases; mass spectrometry apparatus; spectrograph apparatus; data processing equipment, namely, couplers; downloadable computer software for use in medical and clinical analysis and disease diagnostics for analyzing medical data to assist in providing clinical interpretations; computer hardware; downloadable electronic publications in the nature of newsletters, reports and brochures in the field of science and medicine; data processing apparatus with artificial intelligence; downloadable artificial intelligence and machine learning software for analyzing medical data to assist in providing clinical interpretations in the field of medical and clinical analysis and disease diagnostics; research laboratory analysers for measuring, testing and analysing blood and other bodily fluids

Medical services; medical care services; health clinic services; healthcare services, namely, medical analysis services for diagnostic and treatment purposes; medical testing and analysis services for diagnostic purposes, and preparation of reports relating thereto; providing cancer screening services; providing medical information to medical professionals and patients in the form of medical reports relating to health care matters in the field of biofluid analysis and the detection of diseases; medical testing for diagnostic or treatment purposes; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical analysis services for the diagnosis of cancer; medical testing of blood; medical testing for diagnostic and treatment purposes in the nature of liquid biopsy testing; advice, information and consultancy services for all of the aforesaid services

Scientific and technological services, namely, research, design, scientific analysis and scientific testing in the field of medical and clinical analysis and disease diagnostics; industrial analysis and research services in the field of medical and clinical analysis and disease diagnostics; design and development of computer hardware and software; design and development of computer software for use with medical technology; engineering services and design services for scientific equipment and apparatus for microscopy, spectroscopy and scientific imaging; medical research services; clinical research in the field of biofluid analysis and disease detection; medical laboratory services; computer programming in the medical field; design and development of medical technology; design and development of medical diagnostic apparatus; blood analysis services; scientific research for medical purposes in the area of cancerous diseases; research in the field of artificial intelligence; providing on-line non-downloadable software using artificial intelligence for analyzing medical data to assist in providing clinical interpretations in the field of medical and clinical analysis and disease diagnostics; software as a service (SaaS) services featuring software using artificial intelligence for analyzing medical data to assist in providing clinical interpretations in the field of medical and clinical analysis and disease diagnostics; software as a service (SaaS) services featuring software for analyzing medical data to assist in providing clinical interpretations in the field of medical and clinical analysis and disease diagnostics; scientific and technological services, namely, scientific analysis and evaluation of scientific and medical data, in connection with providing clinical interpretations in the field of medical and clinical analysis and disease diagnostics; scientific and technological services, namely, computerized scientific analysis of technical data in the field of medical and clinical analysis and disease diagnostics; scientific and technological services, namely, conducting of scientific experiments and tests in the field of medical and clinical analysis and disease diagnostics; scientific, medical, and technological research services, namely, analysis of scientific data and technical data in the field of medical and clinical analysis and disease diagnostics; design of scientific experiments; provision of scientific reports relating to scientific research in the field of medical and clinical analysis and disease diagnostics, namely, scientific research consulting; advice, information and consultancy services for all of the aforesaid services

Medical apparatus and instruments for analysing biofluids and detecting diseases; diagnostic apparatus for medical purposes, namely, analysing biofluids and detecting diseases; medical apparatus for the treatment of cancer; blood testing apparatus; medical diagnostic instruments and apparatus for the analysis of bodily fluids; medical apparatus, instruments and devices for liquid biopsy analysis; parts and fittings for all the aforesaid goods

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 17, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 17, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 27, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jan 27, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 21, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 31, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 30, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 30, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 30, 2025 TROA
ASSIGNED TO EXAMINER
Oct 20, 2025 DOCK
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Aug 22, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 22, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 22, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 22, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 22, 2025 COAR
REFUSAL PROCESSED BY IB
Aug 15, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 28, 2025 RFCS
REFUSAL PROCESSED BY MPU
Jul 28, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 1, 2025 RFCR
NON-FINAL ACTION WRITTEN
May 30, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 15, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 14, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 14, 2025 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Mar 13, 2025 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 20, 2025 REPR